Việt Nam, Bangladesh, Indonesia, Pakistan and Serbia will receive support from the hub in South Africa, the WHO said in a press conference late Wednesday. “Those countries were vetted by a group of experts and proved that they could absorb the technology and, with targeted training, move to production relatively quickly,” according to the WHO. During the event, the WHO also announced the establishment of a similar hub in the Republic of Korea. These hubs will serve all low- and middle-income countries wishing to produce biologicals, such as vaccines, insulin, monoclonal antibodies and cancer treatments. “One of the key barriers to successful technology transfer in low- and middle-income countries is the lack of a skilled workforce and weak regulatory systems,” said WHO Director-General Tedros Adhanom Ghebreyesus.

Source: The Nation Bangkok February 25, 2022 05:48 UTC